1[1]Coulouarn Y,Lihrmann I,Jegou S,et al.Cloning of the cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord.Proc Natl Sci USA.1998,95:15803-15808.
2[2]Ames RS,Saran HM,Chambers J K,et al.Human urotensin Ⅱ is a potent vasoconstictor and agonist for the orphan receptor GPR14.Nature,1999,401:282-286.
3[3]Charles CJ,Rademaker MT,Richards AM,et al.Urotensin Ⅱ:evidence for cardiac,hepatic and renal production.Peptides,2005,26:2211-2214.
4[4]Gibson A.Complex effects of gillichthys urotensin Ⅱ on rat aortic strips.Br J Pharmacol,1987,91:205-212.
5[5]Gibson A,Conyers S,Bern HA.The influence of urotensin Ⅱ on calcium flux in rat aorta.J Pharm Pharmacol,1988,40:893-895.
6[6]Camarda V,Rizzi A,Calo G,et al.Effects of human urotcnsin Ⅱ in isolated vessels of various species;comparison with other vaseactive agents.Naunyn Schmiedebergs Arch Pharmacol,2002,365:141-149.
7[7]Behm DJ,Harrison sM,Ao Z,et al.Deletion of the UT receptor gene results in the selective loss of urctensin-Ⅱ contractile activity in aortae isolated from UT receptor knockout mice.Br J Pharmacol,2003,139:464-472.
8[8]Ishihata A,Sakai M,Katano Y.Vascular contractile effect of urotensi Ⅱ in young and aged rats:influence of aging and contribution of endothelial nitric oxide.Peptides,2006,27:80-86.
9[9]Ishihata A,Ogaki T,Aita T,et al.Role of prostaglandins in urotensin Ⅱ-induced vasodilatation in the coronary arteries of aged rats.Eur J Pharmacol,2005,523:119-126.
1[1]Martin A,Hefti, Beatrice A, et al. Hans M. Signaling pathways in cardiac myocyte hypertrophy [J]. J Mol Cell Cardiol,1997;29:2873-2892.
2[2]Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord [J]. Proc Natl Acad Sci USA,1998;95(26) :15803-15808.
3[3]Liu Q, Pong SS, Zeng Z, et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14[J]. Biochem Biophys Res Commun,1999;266:174-178.
4[4]Russell FD, Meyers D, Galbraith AJ, et al. Elevated plasma levels of human urotensin II immunoreactivity in congestive heart failure[J]. Am J Physiol Heart Circ Physiol,2003;285(4):H1576-H1581.
5[5]Ames RS, Sarau HM, Chambers JK,et al. Human urotensin II is a potent vasocinstrictor and agonist for the orphan receptor GPR14[J]. Nature,1999;401:282-286.
6[6]Katano Y, Ishihata A, Aita T. Vasodilator effect of urotensinⅡ,one of the most potent vasocontricting factors, on rat coronary arteries [J]. Eur J Pharmacol,2000;402:209-211.
7[8]Zhu W, Zou Y, Shiojima I, et al. Ca2+/calmodulin-depent kinase Ⅱ and calcineurin play critical roles in endothelin-1-induced cardiomycyte hypertrophy [J]. J Biol Chem,2000;275(20):15239-15245.
8[9]Zou YZ, Nagai R, Yamazaki T. UrotensinⅡinduces hypertrophic responses in cultured cardiomyocytes from neonatals rats [J]. FEBS Lett,2001; 508(1):57-60.
9[10]Bueno OF, Molkentin JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death[J]. Circulation Res,2002;91:776-781.
